Envestnet Asset Management Inc Spring Works Therapeutics, Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 120,256 shares of SWTX stock, worth $4.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,256
Previous 112,426
6.96%
Holding current value
$4.62 Million
Previous $4.24 Million
9.02%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SWTX
# of Institutions
239Shares Held
70MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$258 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$216 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$148 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$135 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$131 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.4B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...